What Researchers Did
This review characterized the pathogenesis of radiation-induced fibrosis (RIF) in head and neck squamous cell carcinoma (HNSCC) and summarized promising anti-fibrotic agents under investigation.
What They Found
Radiation-induced fibrosis affects up to 50% of HNSCC patients post-radiation therapy. While pentoxifylline and Vitamin E (PENTOX) are established anti-fibrotic agents, other therapies like hyperbaric oxygen show efficacy for acute toxicities but not substantial fibrotic reduction. Experimental investigations into natural antioxidants and other anti-fibrotic agents indicate anti-RIF potential, but specific studies in HNSCC are limited.
Canadian Relevance
This review does not have a direct Canadian connection or specific Canadian data.
Study Limitations
A key limitation is the lack of specific studies on many promising experimental anti-fibrotic agents in head and neck squamous cell carcinoma patients.